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Rapid signals at the neuromuscularjunction and at synapses between neu-
rons are carried by small molecules, called
neurotransmitters, that are released from
the presynaptic terminal and bind to li-
gand-gated ion channels in the postsynap-
tic membrane. When transmitter binds, a
small pore opens through which ions flow,
resulting in a transient depolarization or
hyperpolarization of the membrane and
translating the chemical signal into an
electrical one. The transmitters at the
neuromuscular junction, and at excitatory
synapses in the central nervous system, are
acetylcholine and glutamate, respectively.
Inhibitory signals are carried by two major
transmitters: glycine, predominantly in the
spinal cord, and g-aminobutyric acid, or
GABA, predominantly in the brain.
Receptors for these transmitters are
important targets for drugs used to treat
mental disorders, or to modulate sleep
and mood. In particular, benzodiaz-
epine-related drugs, such as Valium,
Halcion, and Xanax, which are widely
used for the treatment of anxiety and
insomnia, appear to act by binding di-
rectly to a specific site on the GABA type
A (GABAA) receptor, the principal
GABA-gated ion channel (1, 2). Molec-
ular biologists have spent much produc-
tive effort over the last decade working
out the molecular structures of receptors
for each of the major transmitters, while
biophysicists have unraveled the detailed
kinetics of transmitter binding and gating
(1, 3, 4). The pharmaceutical industry
concentrates enormous resources on de-
termining the specificity and physiolog-
ical consequences of binding of pharma-
cological agents to these receptors.
In recent years, many researchers have
turned to a new issue governing receptor
function: What is the immediate protein
environment of the receptors, and how
does that environment influence receptor
function at different synapses? Receptors
for the rapid transmitters are not distrib-
uted randomly over the surface of the
membrane. Rather, they are ‘‘targeted’’ to
the postsynaptic membrane and are thus
concentrated adjacent to the sites of trans-
mitter release. The acetylcholine receptor
is an extreme example of this process,
clustering into a near crystalline array at
the neuromuscular junction (5). In addi-
tion, the receptors are tightly associated
with a cytoplasmic meshwork of proteins
comprising regulatory enzymes that may
modify the receptor itself to alter its ki-
netics or location, or transmit biochemical
signals deeper into the cytoplasm (6–9).
The N-methyl-D-aspartate (NMDA) sub-
type of the glutamate receptors is an ex-
treme example of this situation. It is
equipped with unusually long carboxyl-
terminal ‘‘tails’’ that extend into the cyto-
plasm and associate with a variety of scaf-
fold and signaling molecules (10).
Several recent papers, including two in
PNAS, by Kneussel et al. (11) and by Chen
et al. (12), have begun to clarify the mech-
anism of clustering of the inhibitory re-
ceptors for glycine and GABA, and the
nature of the matrix of intracellular pro-
teins associated with these receptors. A
possible glycine receptor clustering pro-
tein of ’93 kDa, termed gephyrin (from
the Greek word for bridge), originally was
identified based on its copurification with
the glycine receptor (13). Recent genetic
experiments show that gephyrin is re-
quired for synaptic clustering of both gly-
cine and GABAA receptors (8, 14). These
experiments are puzzling, however, be-
cause gephyrin itself shows no significant
affinity for GABAA receptors in vitro (8).
A partial solution to the puzzle was of-
fered in a set of experiments demonstrat-
ing that a small protein of ’14 kDa,
termed GABARAP (GABAA receptor-
associated protein) can bind to a subunit
of the GABAA receptor (15) and to
gephyrin (11), perhaps forming the miss-
ing physical link between the two (Fig. 1).
GABARAP has an N-terminal tubulin-
binding domain and is closely related to
the previously described ‘‘late-acting in-
tra-Golgi transport factor,’’ termed p16
(11). These findings suggest the hypothesis
that GABARAP may link gephyrin and
the GABAA receptor together as they are
carried along microtubules and targeted
to the proper membrane site (16). The
propensity of gephyrin to form multimeric
assemblies in vitro may be important for
later stabilization of receptor complexes
at the postsynaptic site.
Kneussel et al. (11) have found a f ly in
the hypothetical ointment, however. In
cortical neurons in culture, where
GABARAP previously had been shown
to colocalize with GABAA receptors
(15), they found that GABARAP is pri-
marily in intracellular vesicles and does
not colocalize with gephyrin. Further-
more, in the retina, GABAA receptors
and gephyrin are tightly colocalized, but
GABARAP shows no significant colo-
calization with either of them. Thus, in
neurons GABARAP is not usually clus-
tered at inhibitory synaptic sites; thus, its
interaction with the GABAA receptor
and gephyrin may be important for cel-
lular functions other than receptor an-
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Fig. 1. Gephyrin (93 kDa) binds glycine receptors
and tubulin in vitro and is required for clustering of
glycine and GABAA receptors at synapses; yet it
does not associate with GABAA receptors in vitro.
GABARAP (14 kDa) binds a subunit of the GABAA
receptor, gephyrin, and tubulin in vitro. Further-
more, GABARAP recruits GABAA receptors into
clusters at the plasma membrane in heterologous
quail fibroblast cells. However, GABARAP does not
colocalize with gephyrin or GABAA receptors in
primary neurons. Instead it is associated with intra-
cellular vesicles. The data suggest that GABARAP
may mediate transport or targeting of gephyrin
and GABAA receptors, but another unknown pro-
tein may link gephyrin and the GABAA receptor at
synapses. Chen et al. (12) also show that clustered
receptors recruited to the membrane by GABARAP
in quail cells have a 4-fold reduced affinity for
GABA. If the GABARAP promoted clustering re-
sembles that at synapses, the implication is that
clustering of GABAA receptors and association with
the subcellular cytoskeleton can dramatically alter
their kinetic properties.
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choring. For example, GABARAP may
be involved in intraneuronal receptor
sorting and targeting that precede
andyor initiate receptor clustering at the
synapse (16).
In light of these findings, it is curious
that Chen et al. (12) find that GABARAP
is targeted to the plasma membrane when
expressed in heterologous cells, specifi-
cally quail fibroblast (QF6) cells in cul-
ture. Furthermore, they show that
GABARAP increases the fraction of clus-
tered GABAA receptors at the plasma
membrane and colocalizes with the recep-
tors, when they are expressed together in
the same cells. Kneussel et al. (11) found
that GABARAP and gephyrin become
colocalized in clusters at the plasma mem-
brane when expressed heterologously in
PC12 cells. The apparent contradiction
between the behavior of GABARAP in
neurons and that in QF6 cells and PC12
cells illustrates the danger of extrapolating
too literally to neurons from results in
heterologous cells overexpressing a for-
eign protein.
Taken together, the data suggest that
GABARAP is likely important for early
steps in movement and sorting of GABAA
receptors through the Golgi apparatus
and along microtubules. Genetic modifi-
cation of GABARAP is needed to test
this hypothesis. On the other hand, gephy-
rin is clearly necessary for stable clustering
of GABAA receptors at the synapse, as
shown by genetic experiments and by its
colocalization with the receptor in synap-
tic clusters; but, its mode of association
with the GABAA receptor remains un-
clear.
Even more intriguing, however, is the
finding by Chen et al. (12) in QF6 cells that
clustered GABAA receptors have a signif-
icantly reduced affinity for GABA (from
an EC50 of ’6 mM to ’20 mM) and
altered kinetics of inactivation and desen-
sitization compared with diffuse GABAA
receptors. If the clustering of the receptors
in heterologous cells is similar to that at
synapses, the data imply that physical clus-
tering and accompanying association with
the cytoskeleton can dramatically modu-
late kinetic properties of receptors. Ear-
lier work had indicated that the kinetic
behavior of synaptic GABAA receptors
differs from that of nonsynaptic receptors
(17). However, these data were inter-
preted to suggest that certain combina-
tions of GABAA receptor subunits are
selectively concentrated at synapses. In-
deed, this might well be the case. GABAA
receptors are heteropentameric and are
composed of various combinations of six a
subunits, four b, four g, one d, and two r
subunits (2). Most contain at least two
copies of a and b subunits and at least one
g subunit. Hence, the number of distinct
GABAA receptors is very large. Each
combination can have slightly different
kinetic properties. It is plausible that cer-
tain subunit combinations with character-
istic kinetics might be more readily local-
ized at synapses. The data of Chen et al.
suggest the additional possibility that the
physical clustering of receptors can itself
alter receptor properties significantly. The
change in affinity for GABA is in a range
that could have functional consequences.
A lower affinity and faster dissociation
rate might permit faster channel closing at
the synapse after release of one vesicle’s
worth of GABA.
The brain continues to show us that its
range and subtlety of function are based
on highly tunable properties of each pro-
cessing unit. The next decade will be ex-
citing indeed as we begin to learn how
these processing units (synapses) are
tuned during development, and moment
by moment in adults, so that they work
together to produce appropriate behav-
ioral output.
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